— Know what they know.
Not Investment Advice
PMCUF (OTC) is a cross-listing of PME.AX (ASX). Showing primary listing data.

PME.AX

Pro Medicus Limited
1W: -3.6% 1M: +12.0% 3M: -53.4% YTD: -28.0% 1Y: -54.0% 3Y: +102.0% 5Y: +176.1%
A$119.10 ($82.68)
-1.69 (-1.40%)
 
ASX · Healthcare · Medical - Healthcare Information Services · A$12.6B · Alpha Radar Sell · Power 39
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market CapA$12.6B ($8.8B)
52W Range107.75-336
Volume276,573
Avg Volume452,017
Beta0.49
DividendA$0.62
Analyst Ratings
No analyst coverage
Company Info
CEOSam Aaron Hupert
Employees79
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO Date2000-10-09
450 Swan Street
Richmond, VIC 3121
AU
61 3 9429 8800
About Pro Medicus Limited

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company provides its products under the Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease names. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms